Home › Trial NCT02270307
MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis
- Trial IDNCT02270307
- StatusUnknown
- PhasePhase 2/3
- Study typeInterventional
- SponsorNational Research Center for Hematology, Russia
- Enrollment40
- Start date2014-01
- ConditionsLeukemia · Multiple Myeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.